Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 351 - 378 av 378 resultater
Tid
Selskap
Tittel
Sektor
Kategori
22 Jun 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 14 au 18 Juin 2021
20103015 Pharmaceuticals
Legal
22 Jun 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares Between 14/06/2021 and 18/06/2021
20103015 Pharmaceuticals
Legal
15 Jun 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares between 07/06/2021 and 11/06/2021
20103015 Pharmaceuticals
Legal
15 Jun 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 7 au 11 Juin 2021
20103015 Pharmaceuticals
Legal
11 Jun 2021
07:00 CEST
IPSEN
ISPRM 2021: New Ipsen Analysis Highlights Potential Treatment Gap in Adults Living With Spasticity
20103015 Pharmaceuticals
Other subject
11 Jun 2021
07:00 CEST
IPSEN
ISPRM 2021 : une nouvelle analyse d’Ipsen met en évidence de potentielles disparités dans le traitement de la spasticité chez l’adulte
20103015 Pharmaceuticals
Other subject
10 Jun 2021
18:00 CEST
IPSEN
Ipsen: Monthly Information Relative to the Total Number of Voting Rights and Shares Composing the Share Capital
20103015 Pharmaceuticals
Other subject
10 Jun 2021
18:00 CEST
IPSEN
Ipsen : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
20103015 Pharmaceuticals
Other subject
08 Jun 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 31 mai au 4 juin 2021
20103015 Pharmaceuticals
Legal
08 Jun 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares between 31/05/2021 and 04/06/2021
20103015 Pharmaceuticals
Legal
07 Jun 2021
14:00 CEST
IPSEN
Exelixis et Ipsen présentent lors de la réunion de l’ASCO 2021 les résultats détaillés de l’étude de Phase III évaluant le cabozantinib chez des patients atteints d’un cancer de la thyroïde différencié
20103015 Pharmaceuticals
Other subject
07 Jun 2021
14:00 CEST
IPSEN
Exelixis and Ipsen Announce Detailed Results from Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Presented at ASCO 2021
20103015 Pharmaceuticals
Other subject
02 Jun 2021
07:00 CEST
IPSEN
Ipsen lance un programme de rachat d’actions pour couvrir son programme d’attribution d’actions aux salariés et son nouveau plan d’actionnariat salarié
20103015 Pharmaceuticals
Other subject
02 Jun 2021
07:00 CEST
IPSEN
Ipsen Initiates a Share Buy-back Program to Cover Its Performance and Employee Share Plans
20103015 Pharmaceuticals
Other subject
01 Jun 2021
19:00 CEST
IPSEN
Ipsen annonce le lancement d'une opération d’actionnariat salarié
20103015 Pharmaceuticals
Other subject
01 Jun 2021
19:00 CEST
IPSEN
Ipsen Announces the Launch of an Employee Shareholding Plan
20103015 Pharmaceuticals
Other subject
28 May 2021
19:49 CEST
IPSEN
Ipsen confirme l'acceptation par les autorités réglementaires américaines (FDA) de la demande d'homologation du palovarotène comme premier traitement potentiel de la FOP
20103015 Pharmaceuticals
Other subject
28 May 2021
19:49 CEST
IPSEN
Ipsen Confirms U.S. FDA Accepts New Drug Application for Palovarotene as the First Potential Treatment Worldwide for Fibrodysplasia Ossificans Progressiva (FOP)
20103015 Pharmaceuticals
Other subject
27 May 2021
19:00 CEST
IPSEN
Combined Shareholders’ Meeting of Ipsen S.A. Held on 27 May 2021
20103015 Pharmaceuticals
General meeting / Board Meeting
27 May 2021
19:00 CEST
IPSEN
ASSEMBLEE GENERALE MIXTE DES ACTIONNAIRES DE LA SOCIETE IPSEN S.A. DU 27 MAI 2021
20103015 Pharmaceuticals
General meeting / Board Meeting
27 May 2021
07:00 CEST
IPSEN
Ipsen: Description of the Regulatory Framework of the Share Repurchase Program Proposed by the Board of Directors to Be Approved at the Combined Shareholders’ Meeting on 27 May 2021 (17th resolution)
20103015 Pharmaceuticals
Other subject
27 May 2021
07:00 CEST
IPSEN
Ipsen : Descriptif du cadre réglementaire du programme de rachat d’actions soumis par le Conseil d’administration à l’approbation de l’Assemblée Générale Mixte des actionnaires du 27 mai 2021 (17ème résolution)
20103015 Pharmaceuticals
Other subject
12 May 2021
18:30 CEST
IPSEN
Ipsen : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
20103015 Pharmaceuticals
Other subject
12 May 2021
18:30 CEST
IPSEN
Ipsen: Monthly Information Relative to the Total Number of Voting Rights and Shares Composing the Share Capital
20103015 Pharmaceuticals
Other subject
11 May 2021
23:00 CEST
IPSEN
Ipsen Opts-in to Join Exelixis With Ongoing Development of Cabometyx® for People Living With a Form of Thyroid Cancer, Based on Promising Interim Results
20103015 Pharmaceuticals
Other subject
11 May 2021
23:00 CEST
IPSEN
Ipsen exerce son option de licence et rejoint Exelixis dans le développement de Cabometyx® pour les patients atteintsde cancer de la thyroïde, sur la base de résultats intermédiaires prometteurs
20103015 Pharmaceuticals
Other subject
05 May 2021
18:00 CEST
IPSEN
Ipsen: Information Relating to the Combined Shareholders’ Meeting of 27 May 2021
20103015 Pharmaceuticals
Other subject
05 May 2021
18:00 CEST
IPSEN
IPSEN : INFORMATIONS CONCERNANT LA TENUE DE L’ASSEMBLEE GENERALE MIXTE DU 27 MAI 2021
20103015 Pharmaceuticals
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
6
7
8
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva